[1] RANI S, RITTER T. The Exosome - A Naturally Secreted Nanoparticle and its Application to Wound Healing. Adv Mater. 2016;28(27):5542-5552.
[2] TRICCO AC, COGO E, ISARANUWATCHAI W, et al. A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types. BMC Med. 2015;13:90.
[3] GUO S, DIPIETRO LA. Factors affecting wound healing. J Dent Res. 2010; 89(3):219-229.
[4] MOON HS, BURM JS, YANG WY, et al. Prognosis of full-thickness skin defects in premature infants. Arch Plast Surg. 2012;39(5):463-468.
[5] VIG K, CHAUDHARI A, TRIPATHI S, et al. Advances in Skin Regeneration Using Tissue Engineering. Int J Mol Sci. 2017;18(4):789.
[6] 王新刚,吴攀,翁婷婷,等.浅议目前组织工程皮肤研发面临的关键问题[J].中华损伤与修复杂志,2017,12(3):164-168.
[7] POOL M, LEUVENINK H, MOERS C. Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation? Int J Mol Sci. 2019;20(18):4614.
[8] BADIAVAS EV. The potential of bone marrow cells to orchestrate homeostasis and healing in skin. Blood Cells Mol Dis. 2004;32(1):21-23.
[9] BADIAVAS EV, ABEDI M, BUTMARC J, et al. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003;196(2):245-250.
[10] 沈国良,苏本玄,林伟,等.β射线照射皮肤损伤创面注射骨髓间充质干细胞后的创面愈合[J].中国组织工程研究,2013,17(6):951-956.
[11] FALANGA V, IWAMOTO S, CHARTIER M, et al.Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13(6):1299-1312.
[12] DJOUAD F, PLENCE P, BONY C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102(10):3837-3844.
[13] RASULOV MF, VASILCHENKOV AV, ONISHCHENKO NA, et al. First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med. 2005;139(1):141-144.
[14] GAMELLI RL, PAXTON TP, O’REILLY M. Bone marrow toxicity by silver sulfadiazine. Surg Gynecol Obstet. 1993;177(2):115-120.
[15] ZUK PA, ZHU M, ASHJIAN P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-4295.
[16] KIM WS, PARK BS, SUNG JH. Protective role of adipose-derived stem cells and their soluble factors in photoaging. Arch Dermatol Res. 2009;301(5): 329-336.
[17] KIM WS, PARK BS, SUNG JH, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48(1):15-24.
[18] SYROMIATNIKOVA V, IDRISOVA K, MASGUTOVA G, et al. Analyzing the Effectiveness of Adipose Tissue Stem Cell and Microvesicle Therapy in Premature Skin Aging Caused by Chronic Exposure to Ultraviolet Radiation. BioNanoScience. 2020;10(4): 991-997.
[19] SUARTZ CV, GAIBA S, FRANÇA JP, et al. Adipose-derived stem cells (ADSC) in the viability of random skin flap in rats. Acta Cir Bras. 2014;29 Suppl 2:6-9.
[20] TYEB S, SHIEKH PA, VERMA V, et al. Adipose-Derived Stem Cells (ADSCs) Loaded Gelatin-Sericin-Laminin Cryogels for Tissue Regeneration in Diabetic Wounds. Biomacromolecules. 2020;21(2):294-304.
[21] ENCISO N, AVEDILLO L, FERMÍN ML, et al. Regenerative potential of allogeneic adipose tissue-derived mesenchymal cells in canine cutaneous wounds. Acta Vet Scand. 2020;62(1):13.
[22] 韩兵,范金财.脂肪间充质干细胞在抑制博来霉素诱导裸鼠皮肤纤维化方面的作用[J].中华整形外科杂志,2019,35(2):182-188.
[23] CAN A, KARAHUSEYINOGLU S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007; 25(11):2886-2895.
[24] MENG X, SUN B, XIAO Z. Comparison in transcriptome and cytokine profiles of mesenchymal stem cells from human umbilical cord and cord blood. Gene. 2019;696:10-20.
[25] SUN L, ZHANG X, SONG Q, et al. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Cancer Lett. 2021;500:132-146.
[26] LIU L, YU Y, HOU Y, et al. Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats. PLoS One. 2014;9(2):e88348.
[27] WANG Y, HAN ZB, MA J, et al. A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev. 2012;21(9):1401-1408.
[28] DING DC, CHANG YH, SHYU WC, et al. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339-347.
[29] JIN HJ, BAE YK, KIM M, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986-18001.
[30] VELPULA KK, DASARI VR, RAO JS. The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme. Cell Cycle. 2012;11(12):2303-2313.
[31] 程文广,黄正根,贺伟峰,等.应用人脐带血间充质干细胞修复小鼠皮肤缺损创面[J].中华创伤杂志,2008,24(4):298-301.
[32] FARHADIHOSSEINABADI B, FARAHANI M, TAYEBI T, et al. Amniotic membrane and its epithelial and mesenchymal stem cells as an appropriate source for skin tissue engineering and regenerative medicine. Artif Cells Nanomed Biotechnol. 2018;46(sup2):431-440.
[33] SHI CS, WANG DL, SUN J, et al. Influence of human amniotic mesenchymal stem cells on macrophage phenotypes and inflammatory factors in full-thickness skin wounds of mice. Zhonghua Shao Shang Za Zhi. 2020;36(4): 288-296.
[34] TANG K, WU J, XIONG Z, et al. Human acellular amniotic membrane: A potential osteoinductive biomaterial for bone regeneration. J Biomater Appl. 2018;32(6):754-764.
[35] XIAO S, HUANG G, WEI Z, et al. IL-10 Gene-Modified Human Amniotic Mesenchymal Stem Cells Augment Regenerative Wound Healing by Multiple Synergistic Effects. Stem Cells Int. 2019;2019:9158016.
[36] ZHU Y, YANG Y, ZHANG Y, et al. Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials. Stem Cell Res Ther. 2014;5(2):48.
[37] ZVAIFLER NJ, MARINOVA-MUTAFCHIEVA L, ADAMS G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2(6): 477-488.
[38] LI S, HUANG KJ, WU JC, et al. Peripheral blood-derived mesenchymal stem cells: candidate cells responsible for healing critical-sized calvarial bone defects. Stem Cells Transl Med. 2015;4(4):359-368.
[39] HE Q, WAN C, LI G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25(1):69-77.
[40] DALLE CARBONARE L, VALENTI MT, ZANATTA M, et al. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009;60(11):3356-3365.
[41] MARTINELLO T, GOMIERO C, PERAZZI A, et al. Allogeneic mesenchymal stem cells improve the wound healing process of sheep skin. BMC Vet Res. 2018;14(1):202.
[42] FU WL, ZHOU CY, YU JK. A new source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model. Am J Sports Med. 2014; 42(3):592-601.
[43] PEPLOW PV, CHATTERJEE MP. A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration. Cytokine. 2013; 62(1):1-21.
[44] MONTESANO R, ORCI L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci U S A. 1988;85(13):4894-4897.
[45] SHAH M, FOREMAN DM, FERGUSON MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108 ( Pt 3):985-1002.
[46] LICHTMAN MK, OTERO-VINAS M, FALANGA V. Transforming growth factor beta (TGF-beta) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016;24(2):215-222.
[47] BOCK O, YU H, ZITRON S, et al. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol. 2005;85(3):216-220.
[48] 赵佳佳,杨丕波,韩传火,等.大鼠皮肤创伤修复过程中转化生长因子β1和β3的表达[J].中国组织工程研究,2013,17(20):3643-3649.
[49] KAISER S, SCHIRMACHER P, PHILIPP A, et al. Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice. J Invest Dermatol. 1998;111(6):1145-1152.
[50] COHEN S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555-1562.
[51] HUANG S, LU G, WU Y, et al. Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair. J Dermatol Sci. 2012;66(1):29-36.
[52] YOU DH, NAM MJ. Effects of human epidermal growth factor gene-transfected mesenchymal stem cells on fibroblast migration and proliferation. Cell Prolif. 2013;46(4):408-415.
[53] DETMAR M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci. 2000;24 Suppl 1:S78-84.
[54] FONG GH, ROSSANT J, GERTSENSTEIN M, et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376(6535):66-70.
[55] TERMAN BI, DOUGHER-VERMAZEN M, CARRION ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 1992;187(3):1579-1586.
[56] ZHANG F, YANG F, HU EC, et al. Vascular endothelial growth factor gene therapy in improvement of skin paddle survival in a rat TRAM flap model. J Reconstr Microsurg. 2005;21(6):391-396.
[57] GIUNTA RE, HOLZBACH T, TASKOV C, et al. AdVEGF165 gene transfer increases survival in overdimensioned skin flaps. J Gene Med. 2005;7(3): 297-306.
[58] YU D, LI S, WANG S, et al. Development and Characterization of VEGF165-Chitosan Nanoparticles for the Treatment of Radiation-Induced Skin Injury in Rats. Mar Drugs. 2016;14(10):182.
[59] JEON HH, YU Q, LU Y, et al. FOXO1 regulates VEGFA expression and promotes angiogenesis in healing wounds. J Pathol. 2018;245(3):258-264.
[60] BOWEN-POPE DF, RAINES EW. History of discovery: platelet-derived growth factor. Arterioscler Thromb Vasc Biol. 2011;31(11):2397-2401.
[61] LEE CH, LIU KS, CHENG CW, et al. Codelivery of Sustainable Antimicrobial Agents and Platelet-Derived Growth Factor via Biodegradable Nanofibers for Repair of Diabetic Infectious Wounds. ACS Infect Dis. 2020;6(10):2688-2697.
[62] PARAMASIVAM T, MAITI SK, PALAKKARA S, et al. Effect of PDGF-B Gene-Activated Acellular Matrix and Mesenchymal Stem Cell Transplantation on Full Thickness Skin Burn Wound in Rat Model. Tissue Eng Regen Med. 2020 Nov 3. doi: 10.1007/s13770-020-00302-3. Online ahead of print.
[63] DEPTUŁA M, KARPOWICZ P, WARDOWSKA A, et al. Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds. Adv Wound Care (New Rochelle). 2020;9(12):657-675.
[64] POWERS CJ, MCLESKEY SW, WELLSTEIN A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7(3):165-197.
[65] CZYZ M. Fibroblast Growth Factor Receptor Signaling in Skin Cancers. Cells. 2019;8(6):540.
[66] TAKABAYASHI Y, KUWABARA M, SATO Y, et al. FGF-2-containing dalteparin/protamine nanoparticles (FGF-2&D/P NPs) ameliorate UV-induced skin photoaging in hairless mice. J Plast Surg Hand Surg. 2018;52(6):375-381.
[67] ROBSON MC, PHILLIPS TJ, FALANGA V, et al. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 2001;9(5):347-352.
[68] TAGASHIRA S, HARADA H, KATSUMATA T, et al. Cloning of mouse FGF10 and up-regulation of its gene expression during wound healing. Gene. 1997;197(1-2):399-404.
[69] BAKHSHAYESH M, SOLEIMANI M, MEHDIZADEH M, et al. Effects of TGF-β and b-FGF on the potential of peripheral blood-borne stem cells and bone marrow-derived stem cells in wound healing in a murine model. Inflammation. 2012;35(1):138-142.
[70] RINSCH C, QUINODOZ P, PITTET B, et al. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 2001;8(7): 523-533.
[71] CHAUDHARI AA, VIG K, BAGANIZI DR, et al. Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review. Int J Mol Sci. 2016;17(12):1974.
[72] GIL-CIFUENTES L, JIMÉNEZ RA, FONTANILLA MR. Evaluation of collagen type I scaffolds including gelatin-collagen microparticles and Aloe vera in a model of full-thickness skin wound. Drug Deliv Transl Res. 2019;9(1):25-36.
[73] ZARE-GACHI M, DAEMI H, MOHAMMADI J, et al. Improving anti-hemolytic, antibacterial and wound healing properties of alginate fibrous wound dressings by exchanging counter-cation for infected full-thickness skin wounds. Mater Sci Eng C Mater Biol Appl. 2020;107:110321.
[74] ARASTEH S, KHANJANI S, GOLSHAHI H, et al. Efficient Wound Healing Using a Synthetic Nanofibrous Bilayer Skin Substitute in Murine Model. J Surg Res. 2020;245:31-44.
[75] NAMVIRIYACHOTE N, MUANGMAN P, CHINAROONCHAI K, et al. Polyurethane-biomacromolecule combined foam dressing containing asiaticoside: fabrication, characterization and clinical efficacy for traumatic dermal wound treatment. Int J Biol Macromol. 2020;143:510-520.
[76] CHEN YW, LU CH, SHEN MH, et al. In vitro evaluation of the hyaluronic acid/alginate composite powder for topical haemostasis and wound healing. Int Wound J. 2020;17(2):394-404.
[77] TORT S, DEMIRÖZ FT, COŞKUN CEVHER Ş, et al. The effect of a new wound dressing on wound healing: Biochemical and histopathological evaluation. Burns. 2020;46(1):143-155.
[78] SHAKESPEARE PG. The role of skin substitutes in the treatment of burn injuries. Clin Dermatol. 2005;23(4):413-418. |